These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25178697)

  • 41. Predictive Value of FMO3 Variants on Plasma Disposition and Adverse Reactions of Oral Voriconazole in Febrile Neutropenia.
    Wang X; Zhao J; Wen T; Liao X; Luo B
    Pharmacology; 2021; 106(3-4):202-210. PubMed ID: 32998136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Agarwal R; Dhooria S; Sehgal IS; Aggarwal AN; Garg M; Saikia B; Chakrabarti A
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30049743
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetic/Pharmacodynamic Analysis of Voriconazole Against Candida spp. and Aspergillus spp. in Allogeneic Stem Cell Transplant Recipients.
    Perez-Pitarch A; Guglieri-Lopez B; Ferriols-Lisart R; Pérez A; Ezquer-Garín C; Hernández-Boluda JC; Piñana JL; Navarro D; Solano C; Alós-Almiñana M
    Ther Drug Monit; 2019 Dec; 41(6):740-747. PubMed ID: 31136417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients.
    Zhao YC; Lin XB; Zhang BK; Xiao YW; Xu P; Wang F; Xiang DX; Xie XB; Peng FH; Yan M
    Clin Transl Sci; 2021 Mar; 14(2):702-711. PubMed ID: 33202102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations.
    Hicks JK; Gonzalez BE; Zembillas AS; Kusick K; Murthy S; Raja S; Gordon SM; Hanna R
    Pharmacogenomics; 2016 May; 17(7):663-7. PubMed ID: 27143031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Painful and swollen hands 3 months after lungs graft: Suracute voriconazole-induced periostitis and exostosis.
    Metayer B; Bode-Milin C; Ansquer C; Haloun A; Maugars Y; Berthelot JM
    Joint Bone Spine; 2017 Jan; 84(1):97-98. PubMed ID: 27117297
    [No Abstract]   [Full Text] [Related]  

  • 47. Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
    Bongomin F; Maguire N; Moore CB; Felton T; Rautemaa-Richardson R
    Mycoses; 2019 Mar; 62(3):217-222. PubMed ID: 30570179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CYP2C19*17 genetic polymorphism--an uncommon cause of voriconazole treatment failure.
    Abidi MZ; D'Souza A; Kuppalli K; Ledeboer N; Hari P
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):46-8. PubMed ID: 25986028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
    Wang J; Zhou M; Xu JY; Zhou RF; Chen B; Wan Y
    JAMA Netw Open; 2020 Oct; 3(10):e2017652. PubMed ID: 33030550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Voriconazole-induced periostitis in stem cell transplant patient.
    Malek AE; Skaff Y; Mulanovich VE
    Infection; 2020 Oct; 48(5):809-810. PubMed ID: 32430648
    [No Abstract]   [Full Text] [Related]  

  • 51. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
    Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
    Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
    Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.
    Hicks JK; Quilitz RE; Komrokji RS; Kubal TE; Lancet JE; Pasikhova Y; Qin D; So W; Caceres G; Kelly K; Salchert YS; Shahbazian K; Abbas-Aghababazadeh F; Fridley BL; Velez AP; McLeod HL; Greene JN
    Clin Pharmacol Ther; 2020 Mar; 107(3):563-570. PubMed ID: 31549389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
    Thien SY; Chung SJ; Tan AL; Hwang WY; Tan BH; Tan TT
    Transpl Infect Dis; 2016 Oct; 18(5):768-772. PubMed ID: 27425395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature.
    Lopez JL; Tayek JA
    Drug Metab Dispos; 2016 Jan; 44(1):124-6. PubMed ID: 26502771
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Takahashi T; Smith AR; Jacobson PA; Alharbi AF; Fisher J; Rubin NT; Kirstein MN
    Int J Clin Pharmacol Ther; 2021 Jun; 59(6):442-446. PubMed ID: 33560212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rare Infant Case of Pulmonary Aspergilloma Highlighting Common Challenges With Voriconazole Dosing.
    Abo YN; Gwee A; Osowicki J
    Pediatr Infect Dis J; 2021 Mar; 40(3):227-230. PubMed ID: 33565811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxic epidermal necrolysis due to voriconazole: case report and review.
    Gomulka J; Wilson BD; Joyce JC
    Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two methods for therapeutic drug monitoring of voriconazole: act according to circumstances.
    Zhou HX; Chen X; Ji HJ
    Eur J Hosp Pharm; 2020 Jul; 27(4):248. PubMed ID: 32587087
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.